Serving the Society Since 1986
高级搜索
Volume 28 Issue 1
February 2013

    Yun Wang and Xinwen Chen. How the Key Finds its Door – Identification of HBV Receptor[J]. Virologica Sinica, 2013, 28(1): 1-2. doi: 10.1007/s12250-013-3301-1
    Citation: Yun Wang, Xinwen Chen. How the Key Finds its Door – Identification of HBV Receptor .VIROLOGICA SINICA, 2013, 28(1) : 1-2.  http://dx.doi.org/10.1007/s12250-013-3301-1
    shu

    How the Key Finds its Door-Identification of HBV Receptor

    cstr: 32224.14.s12250-013-3301-1

    • Skate Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, China

    • 通讯作者： Yun Wang, wangyun@wh.iov.cn; 
    • 收稿日期： 2012-12-28
      录用日期： 2012-12-31

    • HBV is the predominant pathogen associated with hepatitis cases in China. Although the HBV replication mechanism has been extensively documented in recent years, the virus entry mechanism remains elusive; in particular, the HBV receptor has yet to be identified. Recently, a research team led by Dr. Wenhui Li finally identified Sodium taurocholate cotransporting polypeptide (NTCP) as the receptor for HBV infection of hepatocytes (Yan H, et al., 2012). This review highlights their research strategy, as well as the significance of the identification of the HBV receptor.

    How the Key Finds its Door – Identification of HBV Receptor

    • Skate Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, China

    • Corresponding author: Yun Wang, wangyun@wh.iov.cn
    • Received Date: 28 December 2012
      Accepted Date: 31 December 2012
    • HBV is the predominant pathogen associated with hepatitis cases in China. Although the HBV replication mechanism has been extensively documented in recent years, the virus entry mechanism remains elusive; in particular, the HBV receptor has yet to be identified. Recently, a research team led by Dr. Wenhui Li finally identified Sodium taurocholate cotransporting polypeptide (NTCP) as the receptor for HBV infection of hepatocytes (Yan H, et al., 2012). This review highlights their research strategy, as well as the significance of the identification of the HBV receptor.
    • 加载中

      1. Barrera A, Guerra B, Notvall L and Lanford R E. 2005. Mapping of the hepatitis B virus pre-S1 domain involved in receptor recognition. J Virol, 79: 9786-9798.
          doi: 10.1128/JVI.79.15.9786-9798.2005

      2. De Falco S, Ruvoletto M G, Verdoliva A, Ruvo M, Raucci A, Marino M, Senatore S, Cassani G, Alberti A, Pontisso P and Fassina G. 2001. Cloning and expression of a novel hepatitis B virus-binding protein from HepG2 cells. J Biol Chem, 276: 36613-36623.
          doi: 10.1074/jbc.M102377200

      3. Deng Q, Zhai J W, Michel M L, Zhang J, Qin J, Kong Y Y, Zhang X X, Budkowska A, Tiollais P, Wang Y and Xie Y H. 2007. Identification and characterization of peptides that interact with hepatitis B virus via the putative receptor binding site. J Virol, 81: 4244-4254.
          doi: 10.1128/JVI.01270-06

      4. Engelke M, Mills K, Seitz S, Simon P, Gripon P, Schnolzer M and Urban S. 2006. Characterization of a hepatitis B and hepatitis delta virus receptor binding site. Hepatology, 43: 750-760.
          doi: 10.1002/hep.v43:4

      5. Glebe D, Urban S, Knoop E V, Cag N, Krass P, Grun S, Bulavaite A, Sasnauskas K and Gerlich W H. 2005. Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes. Gastroenterology, 129: 234-245.
          doi: 10.1053/j.gastro.2005.03.090

      6. Gripon P, Cannie I and Urban S. 2005. Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein. J Virol, 79: 1613-1622.
          doi: 10.1128/JVI.79.3.1613-1622.2005

      7. Neurath A R, Strick N and Sproul P. 1992. Search for hepatitis B virus cell receptors reveals binding sites for interleukin 6 on the virus envelope protein. J Exp Med, 175: 461-469.
          doi: 10.1084/jem.175.2.461

      8. Schulze A, Schieck A, Ni Y, Mier W and Urban S. 2010. Fine mapping of pre-S sequence requirements for hepatitis B virus large envelope protein-mediated receptor interaction. J Virol, 84: 1989-2000.
          doi: 10.1128/JVI.01902-09

      9. Yan H, Zhong G, Xu G, He W, Jing Z, Gao Z, Huang Y, Qi Y, Peng B, Wang H, Fu L, Song M, Chen P, Gao W, Ren B, Sun Y, Cai T, Feng X, Sui J and Li W. 2012. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. elife, 1: e00049.

    • 加载中
    PDF

    Article Metrics

    Article views(4098) PDF downloads(18) Cited by(0)

    Related
    Proportional views
      通讯作者: 陈斌, bchen63@163.com
      • 1. 

        沈阳化工大学材料科学与工程学院 沈阳 110142

      1. 本站搜索
      2. 百度学术搜索
      3. 万方数据库搜索
      4. CNKI搜索

      How the Key Finds its Door – Identification of HBV Receptor

        Corresponding author: Yun Wang, wangyun@wh.iov.cn
      • Skate Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, China
      • Received Date: 28 December 2012
      • Accepted Date: 31 December 2012

      Abstract: HBV is the predominant pathogen associated with hepatitis cases in China. Although the HBV replication mechanism has been extensively documented in recent years, the virus entry mechanism remains elusive; in particular, the HBV receptor has yet to be identified. Recently, a research team led by Dr. Wenhui Li finally identified Sodium taurocholate cotransporting polypeptide (NTCP) as the receptor for HBV infection of hepatocytes (Yan H, et al., 2012). This review highlights their research strategy, as well as the significance of the identification of the HBV receptor.

        HTML